Achieving Universal Access for Human Immunodeficiency Virus and Tuberculosis: Potential Prevention Impact of an Integrated Multi-Disease Prevention Campaign in Kenya

<table>Comparison of the CD4 cell count distribution in Nyanza Province (red; KAIS survey) and the Kisii Hospital cohort (blue). The data for the hospital cohort are scaled to match the KAIS data for the lowest CD4 cell count range and the differences in the heights of the bars for the higher ranges show the proportion that are missed in the hospital cohort.</table>

AIDS Research and Treatment

fig2

Figure 2

Figure 2: Achieving Universal Access for Human Immunodeficiency Virus and Tuberculosis: Potential Prevention Impact of an Integrated Multi-Disease Prevention Campaign in Kenya 

Figure 2 | Achieving Universal Access for Human Immunodeficiency Virus and Tuberculosis: Potential Prevention Impact of an Integrated Multi-Disease Prevention Campaign in Kenya 